Erez Kaminski is the CEO and Founder of Ketryx Corporation, a company striving to create innovative new approaches to regulated software development. Over the last decade, he worked in various industries, including computational mathematics, biotech, and energy, developing mission-critical applications like monitoring systems for pharmaceutical equipment and AI for medication management. Erez is deeply concerned with improving patient care and health outcomes with software solutions. Through Ketryx, he is redefining the complex process of regulated software development and empowering others to change lives and improve software safety and quality.
Prior to Ketryx, Erez worked with Amgen, the world’s largest biotechnology company, as the head of AI/ML for their medical device division and with Wolfram Research, the builders of Mathematica and Wolfram|Alpha. Throughout his career Erez has helped companies large and small build and improve the safety and reliability of their software. He now dedicates his time and focus to improving patient safety and expanding the possibilities for regulated software development, especially as they pertain to AI/ML and Open Source software.
Medical devices, traditionally from a software perspective, have the minimal amount of software they can have on them, and that software was not connected to anything. It was not changed often and that comes into stark contrast to what’s about to happen in this industry and what’s already unfolding.
Erez Kaminski, CEO & Founder of Ketryx, spoke about the reality of developing cloud-based software in a changing regulatory environment.